Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.46 - $1.05 $10,166 - $23,205
-22,100 Reduced 34.53%
41,900 $20,000
Q3 2022

Nov 14, 2022

SELL
$0.93 - $1.18 $46,500 - $59,000
-50,000 Reduced 43.86%
64,000 $60,000
Q2 2022

Aug 15, 2022

SELL
$0.76 - $1.25 $9,120 - $15,000
-12,000 Reduced 9.52%
114,000 $124,000
Q1 2022

May 16, 2022

BUY
$1.13 - $1.93 $40,679 - $69,480
36,000 Added 40.0%
126,000 $155,000
Q3 2021

Nov 15, 2021

BUY
$3.18 - $5.17 $286,200 - $465,300
90,000 New
90,000 $299,000
Q2 2021

Aug 16, 2021

SELL
$3.53 - $6.1 $134,140 - $231,800
-38,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.55 - $35.0 $210,900 - $1.33 Million
38,000 New
38,000 $211,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About GRAYBUG VISION, INC.


  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.